Page 255 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 255

232   Assurance of sterility for sensitive combination products and materials


            practicable for a particular product. Points to consider as far as feasibility
          include extent of research or development, length of time for regulatory
          approval, effect of modifications, extent of supporting studies or testing,
          supply chain availability, and other points associated with practicality of an
          extensive delay or redesign.
             The revision of AAMI ST67 that is in process will include several
          changes and additions to the current version. One main change is that ST67
          will more closely harmonize with ISO TS 19930 in language, format, and
          inclusions. AAMI ST67 not only embraces the guidance in ISO TS 19930
          but also provides, as a national standard, requirements that can be used to
          support the choice of an alternative SAL.
             As in ISO TS 19930, the ultimate goal in AAMI ST67 is to seek an
          appropriate balance between the clinical benefit of a product and patient
          safety and the scale of risk and feasibility of what might be required in re-
                                                             −6
          sources versus logistics to sterilize to a maximal SAL of 10 , compared to
          using an alternative SAL or selecting aseptic processing.
             Regarding AAMI ST67, ISO 13408, and any future published standards,
          the FDA maintains a searchable database of current “FDA-recognized con-
          sensus standards” at  https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/
          cfStandards/search.cfm. This  database  enables  the  user  to determine  if  a
          standard is currently FDA-recognized, and if so, it provides the user with
          a “Supplemental Information Sheet” (SIS). The SIS will enable the user to
          identify the edition of the standard that is recognized based on publication
          date, identify the individual subparts that are recognized (e.g., part 1, 2, or 3),
          and provide additional valuable information in the “Extent of Recognition”
          and “Relevant FDA Guidance and/or Supportive Publications” sections.

          9.5.2  European standards for terminal sterilization
          EN 556-1, Sterilization of medical devices—Requirements for medical de-
          vices to be designated “STERILE”—Part 1: Requirements for terminally
          sterilized medical devices was initially published in 1994 to provide require-
          ments for designating devices as sterile that would be consistent across all
          methods of terminal sterilization. EN 556-1 was updated in 2001 without
          changing the core requirement, a corrigendum was issued in 2006 and
          the standard was subsequently reconfirmed without change. EN 556-1 has
          been harmonized under the Medical Devices Directive and is expected
          to be harmonized under the Medical Devices Regulation. EN 556-1 has
          been adopted by countries outside of the EU, including by Australia, China,
          Israel, and South Africa.
   250   251   252   253   254   255   256   257   258   259   260